Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad?
Use of atypical antipsychotics (AAPs) for attention-deficit/hyperactivity disorder (ADHD) is currently rife and trend of use is on the rise. It is largely off-label driven. Here, we touch on the topic highlighting both merits and demerits of this approach.
Gespeichert in:
Veröffentlicht in: | European psychiatry 2019-10, Vol.62, p.58-59 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Use of atypical antipsychotics (AAPs) for
attention-deficit/hyperactivity disorder (ADHD) is currently rife and trend
of use is on the rise. It is largely off-label driven. Here, we touch on the
topic highlighting both merits and demerits of this approach. |
---|---|
ISSN: | 0924-9338 1778-3585 |
DOI: | 10.1016/j.eurpsy.2019.08.013 |